An approved drug normally used to treat fungal infections could also do the job of a protein channel that is missing or dysfunctional in the lungs of people with cystic fibrosis, operating as a prosthesis on the molecular scale, says new research.
from All Top News -- ScienceDaily https://ift.tt/2O1iS08
No comments:
Post a Comment